Calcium Orotate 100 capsules by Dr. Hans Nieper

Dosage: General Health and Well-being: As an addition to the daily diet, take 2 – 3 tablets with an evening meal, or as directed by a health care professional. Dr. Nieper’s Recommendations: Arterial Spasms: 1 tablet twice a day Arthritis: 1-2 tablets three times a day Back Pain: 2 tablets twice a day Bone Fractures: 2 tablets twice a day Brusing: 2 tablets three times a day Bursitis and tendonitis: 2 tablets twice a day Capillary Fragility: 2-3 tablets twice a day Carpal Tunnel Syndrome: 1 tablet twice a day Chronic Inflammation of the Liver and Atrophied Liver: 1 tablet 3 times a day, always to be combined with 1-2 tablets of 120 mg Lithium Orotate Friedreich’s Ataxia (FA): 1 tablet 3 times a day Inflammation: 1 tablet 3 times a day Leg Cramps: 2 tablets in AM Osteoporosis: 1-3 tablets 3 times a day Psoriasis: 2 tablets twice a day Thrombophlebitis: 1 tablet 3 times a day Technical Information: During Dr. Nieper’s preliminary work with ‘Electrolyte Carriers’ based on aspartic acid, he discovered that orotic acid was also an appropriate ‘carrier’ molecule. It was already known that orotic acid penetrates very easily into the cell and, as an aromatic substance, it possesses high chemical-complexing power enabling the creation of stable mineral compounds (orotates). He found that the orotates pass through the cell’s double-layered outer membrane and are decomposed for utilization only by the inner components of the cell, such as the microsomes and the mitochondria. Biochemist Arthur D. Alexander III, Ph.D., describes the mitochondrial organelles as the cell’s “furnace” where sugars and fats are broken down to produce cellular energy. Furthermore, he reports that “the mineral Orotates have the ability to transport nutrient substances into the cells, maintaining healthy cell growth and averting damage to the mitochondria and other important metabolic structures." Clinical Application: Dr. Nieper reports from his treatments of osteoporosis “the orotate carrier molecule has great affinity for the bone cells, penetrating the interior of the bone cells while transporting critically needed calcium to the depleted bone cells.” In addition, “clinical trials and electron microscopic research (Nieper, Moenninghoff, 1971) indicate the Orotates have specific affinity toward cells of the heart, blood vessels, blood brain barrier and cartilage.” Calcium Orotate is a premier calcium supplement for the discriminating consumer. Calcium orotate is a mineral transporter where calcium is bound to orotic acid, a natural component of whey. It is well absorbed with 70-90% of the compound entering the blood stream in an intact state. This compound is attracted to bone, cartilage, liver, brain and the circulatory system where the molecule can enter the cells of these tissues releasing calcium inside the cell avoiding the hypercalcemia common to other calcium supplements. It is the intracellular delivery of calcium that makes this mineral transporter so powerful in the treatment of: bone and cartilage degeneration, bone fractures, spinal pain, periodontal disease, muscle cramps, inflammation in the liver and autoimmune diseases. Clinical Uses of Calcium Orotate 1. For reduction of the side effects of cortisone. 2. When cartilage degeneration is present. 3. Strengthening of bones such as the hips. 4. For periodontal disease. 5. For muscle-cramping secondary to low calcium. 6. For individuals with asthma. Calcium orotate should be considered in the following conditions: 1. Any decalcification disease (osteoporosis). 2. Bone fractures, especially of the spine. 3. Immune system dysfunctions and inflammation. 4. Cartilage problems caused by rheumatoid arthritis, effects of cortisone or birth control pills. 5. Generalized bone pain. 6. Dorsal spine pain and slipped discs. 7. Hip degeneration (arthrosis) 8. For reclassifying bone metastases Calcium orotate is useful instead of nonspecific calcium supplements, which create hypercalcemia in the blood, but do not necessarily get into tissues that require calcium.